Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06516913 · ClinicalTrials.gov registry record · NA
A Study of Subcutaneous Injection in Healthy Participants
A NA study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06516913 is a NA study that has completed, run by Eli Lilly and Company. The registered enrollment target is 32 participants.
The verdict
NCT06516913, a NA study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a device feasibility study designed to evaluate the practicality of delivering a high-viscosity solution subcutaneously using various injection parameters, including volume, rate, and needle length. The goal is to assess the usability and operational performance of a delivery setup (Havard apparatus syringe pump and related components) to inform design requirements for future large-volume injection devices. No active drug is administered in this study, and no health outcomes are being evaluated. The study duration is approximately 40 days, including screening, injection assessments, and follow-up.
Interventions
- DEVICE Harvard Apparatus syringe pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-07-22 |
| Est. Completion | 2024-09-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06516913
The ClinicalTrials.gov registry entry for NCT06516913 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Harvard Apparatus syringe pump is the first listed.
NCT06516913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06516913 about?
NCT06516913 is a clinical study titled "A Study of Subcutaneous Injection in Healthy Participants". This is a device feasibility study designed to evaluate the practicality of delivering a high-viscosity solution subcutaneously using various injection parameters, including volume, rate, and needle length. The goal is to assess the usability and operational performance of a delivery setup (Havard a...
What is the current status of trial NCT06516913?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-07-22. Estimated completion is 2024-09-07.
What interventions are being tested in trial NCT06516913?
The interventions under investigation include: Harvard Apparatus syringe pump (DEVICE).
Who is sponsoring clinical trial NCT06516913?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.